Market Survey on Alopecia Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Alopecia Treatment Market including Pharmaceuticals, and Devices Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Newly-released Alopecia Treatment Market analysis report by Future Market Insight shows that global sales of the Alopecia Treatment Market in 2021 were held at US$ 8.4 Billion. With a CAGR of 9.5% from2022 to 2032,themarket is projected to reach a valuation of US$ 22.5 Billion by 2032.Themarket through Alopecia Areata is expected to gross significant revenue, accounting for an expected CAGR rate of 9.5% from 2022 to 2032.
Attribute
Details
Global Alopecia Treatment Market (2022)
US$ 9.1 Billion
Global Alopecia Treatment Market (2032)
US$ 22.5 Billion
Global Alopecia Treatment Market CAGR (2022 to 2032)
9.5%
USA Alopecia Treatment Market (2022)
US$ 2.8 Billion
Key Companies Profiled
iRestore Hair Growth System
iGrow Laser
Theradome
Curallux
Lexington Intl., LLC.
LUTRONIC
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of Alopecia Treatment Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Alopecia Treatment Market research by Future Market Insight - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Alopecia Treatment Market increased at around 8.5% CAGR.
Demand for hair-restoration drugs, which often have improved efficacy and minimal side effects, has led to the development of the market for alopecia treatment. For example, cutting-edge treatments including cytokine therapy and regenerative cell therapy are becoming increasingly popular within the field of alopecia treatment.
Hair regrowth is enhanced by cytokine therapy, which causes hair follicle cells to differentiate and proliferate while controlling the hair growth cycle. Combination therapies have also been shown to be clinically effective in the treatment of Alopecia Treatment. Combination therapeutics are currently the most widely used hair loss treatment.
Increased focus on providing hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as increased penetration of advanced hair loss treatment therapies such as stem cell therapy, are set to define the market landscape of the hair loss industry over the forecast period.
The introduction of low-level laser therapy, which helps stimulate hair growth, is expected to boost the number of patients treated for hair loss. Furthermore, the introduction of laser caps, helmets, combs, and bands are expected to boost the market growth. Some of the technologically advanced products on the market include the Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices.
How are the increasing initiatives and growing prevalence of Hair Loss fuelling the Alopecia Treatment Market?
An increase in healthcare spending is being driven by an increase in the number of initiatives being undertaken by organizations such as the National Alopecia Treatment Areata Foundation and the American Hair Loss Association to raise awareness about hair regrowth and treatment options.
The Affordable Care Act of 2010 allows people to purchase health insurance at a low cost, thereby benefiting patients who are financially disadvantaged. This led to an overall increase in treatment rates, driving the market growth. Furthermore, as people become more aware of hair loss, there is a greater demand for painless therapies with few side effects, which is driving up the treatment rate around the world.
The increase in the incidence of Alopecia Treatment is among the primary factors driving the market growth. In the USA in 2018, the American Academy of Dermatology Association (AAD) estimated that roughly Alopecia affected 50 million individuals and 30 million women, more than 50 million men, and 30 million women.
According to The Journal of Clinical and Diagnostic Research (JCDR)'s study, roughly 60% of the population suffers from hair loss, with various factors contributing to the severity of pattern hair loss in both sexes.
The prevalence of chronic diseases such as cancer, Polycystic Ovary Syndrome (PCOS), and rheumatoid arthritis, all of which are linked to the loss of hair, is expected to increase the demand for the treatment of hair loss in the near future. According to the Department of Health and Human Services of the USA, PCOS affects nearly 5 million individuals in the USA.
Find your sweet spots for generating winning opportunities in this market.
Which Region is projected to Offer the Largest Opportunity for Alopecia Treatment Market?
In 2021, North America was the largest market for Alopecia Treatment globally. It is because the country has an advanced healthcare infrastructure, a high disposable income, and a multitude of novel treatment options. Roughly one in 500 to 1,000 individuals are affected by alopecia areata in the USA, according to the National Library of Medicine. The second most common form of alopecia treatment after androgenic alopecia treatment is alopecia treatment areata, one of the most common kinds of alopecia treatment.
Country-wise Analysis
USA Alopecia Treatment Market Analysis
The USA is expected to account for the highest market share of US$ 7.3 Billion by the end of 2032. Alopecia areata is a common autoimmune condition that causes sporadic hair loss. In the USA, it affects approximately 6.8 million people. Furthermore, the region's advanced healthcare infrastructure, combined with strict Alopecia Treatment requirements, is expected to accelerate the advancement of the market in the country.
China Alopecia Treatment Market Analysis
China dominates the Asia Pacific market with a CAGR of 10.9% having an absolute dollar growth opportunity of US$ 1.9 Billion. As more consumers share the incidence of hair loss problems, cosmetic product manufacturers are introducing additional hair care products and drinks that target these individuals, leading to a rise in cosmetics spending in China.
The majority of consumers have consequently perceived the demand as well as the need for natural and organic products for personal hair care. Shampoo and conditioner accounted for the majority of the regional and global organic haircare market in 2019, owing to the massive use of these products.
In China, for instance, Henkel Beauty Care introduced the Schwarzkopf Extra Care Sun Repair Spray Conditioner in 2017, which boasts a highly effective formula combining Monoi Flower Extract and UVA/UVB filtering agents that repair and protect hair from sun and salt damage. Likewise, brand-endorsed hair care products, including conditioners, have gained immense popularity in China.
UK Alopecia Treatment Market Analysis
The market in the UK is projected to reach a valuation of US$ 974 Million by 2032. Growing at a CAGR of 10.2%, the market in the country is projected to gross an absolute dollar opportunity of over US$ 600 Million from 2022 to 2032.
Japan Alopecia Treatment Market Analysis
In Japan, the market is expected to reach US$ 1.2 Billion by 2032, growing at a CAGR of 11.1% during the forecast period. During this period, the market is likely to gross an absolute dollar opportunity of US$ 780 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
What are the insights about Alopecia Revenue through Treatment Type and Sales Channel?
In 2021, the pharmaceutical segment dominated the Alopecia Treatment type. The segment is driven by the low cost of pharmaceutical products and the high use of prescription and over-the-counter drugs. The most common drugs used to treat Alopecia Treatment are Finasteride and Minoxidil.
Finasteride and Minoxidil are the only drugs approved in the USA to treat both Female Pattern Hair Loss (FPHL) and Male Pattern Hair Loss (MPHL) (MPHL). Furthermore, key pharmaceutical companies such as Lilly, Pfizer Inc., and Concert Pharmaceuticals are actively involved in the development of novel Alopecia Treatments, which is expected to drive the market over the forecast period.
Due to the high number of visits to dermatologists for hair loss treatment, the prescription segment dominated the market and accounted for the largest revenue share in 2021. According to the National Library of Medicine, approximately 2.6 million outpatients seek Alopecia areata treatment from dermatologists in the USA each year. Furthermore, a strong product pipeline, rising disposable incomes, and an increase in the prevalence of chronic diseases that lead to hair loss are expected to propel the segment's growth at the fastest rate during the forecast period.
Which Gender Type Offers the Most Lucrative Opportunities for Alopecia Treatment?
Due to the high prevalence of hair loss in the male population worldwide, the market revenue through male Alopecia treatment dominated in 2021. The most common type of Alopecia Treatment in men is androgenetic Alopecia Treatment. A study cited that around 50% of men in their 50s will experience loss of hair, with androgenetic blading accounting for more than 95% of cases.
The female Alopecia Treatment market, on the other hand, is expected to grow at the fastest rate during the forecast period. The market is expected to grow due to rising awareness, lifestyle changes, increased PCOS levels, and a growing trend in cosmetic procedures.
Hair loss affects about one-third of women at some point in their lives. Hair thinning or bald spots affect up to two-thirds of postmenopausal women. Women's hair loss has a greater impact than men's hair loss because it is less socially acceptable for them. The most common cause of hair loss in women is androgenetic Alopecia Treatment. Alopecia Treatment can have a significant impact on a woman's emotional health and quality of life.
Competitive Analysis
iRestore Hair Growth System, iGrow Laser, Theradome, Curallux, LLC, and LUTRONIC are some of the leading players in the Alopecia treatment market. Players in the market are increasingly forming partnerships and licensing agreements to further refine their product lines and expand their operations. For instance, in China, the Central Pharmaceuticals Group partnered with the iGrow laser system.
China Central Pharmaceuticals has exclusive rights to Aspira in China, and Capillus, LLC has partnered with Svenson, a hair loss treatment clinic, to set up distribution rights for laser therapy caps in Europe, Asia-Pacific, and Australia. The expansion with business partners and local associates is anticipated to heighten the utilization of non-toxic hair removal technology.
Some of the recent developments of key Alopecia Treatment providers are as follows:
In Aug 2021, Pfizer Inc. announced the positive results of Phase 2b 3 ALLEGRO, which evaluated an oral once-a-day Ritlecitinib drug in patients with alopecia areata, an autoimmune disease characterized by hair loss on the scalp and can also affect face and body.
In March 2020, the USA Food and Drug Administration (FDA) granted Baricitinib Breakthrough Therapy designation for the treatment of Alopecia Treatment Areata (AA), an autoimmune disorder. The designation of Breakthrough Therapy aims to speed up the development and review of drugs that are intended to treat a serious condition.
Similarly, recent developments related to companies Alopecia Treatment Market have been tracked by the team at Future Market Insight, which is available in the full report.
Market Segments Covered in Alopecia Treatment Market Analysis
By Disease Type:
Alopecia Areata
Cicatricial Alopecia
Traction Alopecia
Alopecia Totalis
Androgenetic Alopecia
Alopecia Universalis
Other Disease Types
By Treatment Type:
Pharmaceuticals
Devices
By Gender:
Male
Female
By Sales Channel:
Prescriptions
OTC
By Region:
North America
Latin America
Europe
Asia-Pacific excluding Japan (APEJ)
Middle East and Africa (MEA)
Frequently Asked Questions
How much is the current worth of the Alopecia Treatment Market?
The global Alopecia Treatment Market is worth more than US$ 8.4 Billion at present.
What is the sales forecast for Alopecia Treatment Market?
The value of the Alopecia Treatment Market is projected to increase at a CAGR of around 9.5% from 2022 to 2032.
What was the last 5 year’s market CAGR?
The value of the Alopecia Treatment Market increased at a CAGR of around 8.5% from 2017 to 2021.
What is a key trend shaping the Alopecia Treatment Market’s growth?
Technological advancements, improved reimbursement scenarios, and rising healthcare expenditures around the world are all driving the Alopecia Treatment market forward.
At what percentage will Alopecia Treatment Market sales register growth in China?
The market of Alopecia Treatment Market in China is projected to expand at a CAGR of around 10.9 % from 2022 to 2032.
What do statistics for the UK and South Korea reveal?
Both the UK and South Korean market is expected to grow at nearly 10.2% from 2022 to 2032.
Table of Content
1. Executive Summary | Alopecia Treatment Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Alopecia demands
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$Billion)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$Billion)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Alopecia demands Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2017 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$Billion) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$Billion) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$Billion) Analysis By Disease Type, 2017 to 2021
8.3. Current and Future Market Size (US$Billion) Analysis and Forecast By Disease Type, 2022 to 2032
8.3.1. Alopecia Areata
8.3.2. Cicatricial Alopecia
8.3.3. Traction Alopecia
8.3.4. Alopecia Totalis
8.3.5. Alopecia Universalis
8.3.6. Androgenetic Alopecia
8.3.7. Other Disease Types
8.4. Market Attractiveness Analysis By Disease Type
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Treatment Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$Billion) Analysis By Treatment Type, 2017 to 2021
9.3. Current and Future Market Size (US$Billion) Analysis and Forecast By Treatment Type, 2022 to 2032
9.3.1. Pharmaceuticals
9.3.2. Devices
9.4. Market Attractiveness Analysis By Treatment Type
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Gender
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$Billion) Analysis By Gender, 2017 to 2021
10.3. Current and Future Market Size (US$Billion) Analysis and Forecast By Gender, 2022 to 2032
10.3.1. Male
10.3.2. Female
10.4. Market Attractiveness Analysis By Gender
11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Sales Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$Billion) Analysis By Sales Channel, 2017 to 2021
11.3. Current and Future Market Size (US$Billion) Analysis and Forecast By Sales Channel, 2022 to 2032
11.3.1. Prescriptions
11.3.2. OTC
11.4. Market Attractiveness Analysis By Sales Channel
12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$Billion) Analysis By Region, 2017 to 2021
12.3. Current Market Size (US$Billion) & Analysis and Forecast By Region, 2022 to 2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
13.4. Market Value (US$Billion) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1.United States of America
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Disease Type
13.4.3. By Treatment Type
13.4.4. By Sales Channel
13.4.5. By Gender
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Disease Type
13.5.3. By Treatment Type
13.5.4. By Sales Channel
13.5.5. By Gender
14. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
14.4. Market Value (US$Billion) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Disease Type
14.4.3. By Treatment Type
14.4.4. By Sales Channel
14.4.5. By Gender
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Disease Type
14.5.3. By Treatment Type
14.5.4. By Sales Channel
14.5.5. By Gender
15. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
15.4. Market Value (US$Billion) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3.United Kingdom
15.4.1.4. Italy
15.4.1.5. Spain
15.4.1.6. Russia
15.4.1.7. Rest of Europe
15.4.2. By Disease Type
15.4.3. By Treatment Type
15.4.4. By Sales Channel
15.4.5. By Gender
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Disease Type
15.5.3. By Treatment Type
15.5.4. By Sales Channel
15.5.5. By Gender
16. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
16.4. Market Value (US$Billion) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. India
16.4.1.5. Australia
16.4.1.6. South Korea
16.4.1.7. Rest of Asia Pacific
16.4.2. By Disease Type
16.4.3. By Treatment Type
16.4.4. By Sales Channel
16.4.5. By Gender
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Disease Type
16.5.3. By Treatment Type
16.5.4. By Sales Channel
16.5.5. By Gender
17. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$Billion) Trend Analysis By Market Taxonomy, 2017 to 2021
17.4. Market Value (US$Billion) & Forecast By Market Taxonomy, 2022 to 2032
17.4.1. By Country
17.4.1.1. UAE
17.4.1.2. South Africa
17.4.1.3. Saudi Arabia
17.4.1.4. Israel
17.4.1.5. Rest of Middle East and Africa
17.4.2. By Disease Type
17.4.3. By Treatment Type
17.4.4. By Sales Channel
17.4.5. By Gender
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Disease Type
17.5.3. By Treatment Type
17.5.4. By Sales Channel
17.5.5. By Gender
18. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.2.2.1. By Disease Type
18.2.2.2. By Treatment Type
18.2.2.3. By Sales Channel
18.2.2.4. By Gender
18.3. Canada Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.3.2.1. By Disease Type
18.3.2.2. By Treatment Type
18.3.2.3. By Sales Channel
18.3.2.4. By Gender
18.4. Mexico Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.4.2.1. By Disease Type
18.4.2.2. By Treatment Type
18.4.2.3. By Sales Channel
18.4.2.4. By Gender
18.5. Brazil Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.5.2.1. By Disease Type
18.5.2.2. By Treatment Type
18.5.2.3. By Sales Channel
18.5.2.4. By Gender
18.6. Germany Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.6.2.1. By Disease Type
18.6.2.2. By Treatment Type
18.6.2.3. By Sales Channel
18.6.2.4. By Gender
18.7. France Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.7.2.1. By Disease Type
18.7.2.2. By Treatment Type
18.7.2.3. By Sales Channel
18.7.2.4. By Gender
18.8. Italy Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.8.2.1. By Disease Type
18.8.2.2. By Treatment Type
18.8.2.3. By Sales Channel
18.8.2.4. By Gender
18.9. Spain Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.9.2.1. By Disease Type
18.9.2.2. By Treatment Type
18.9.2.3. By Sales Channel
18.9.2.4. By Gender
18.10. UK Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.10.2.1. By Disease Type
18.10.2.2. By Treatment Type
18.10.2.3. By Sales Channel
18.10.2.4. By Gender
18.11. Russia Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.11.2.1. By Disease Type
18.11.2.2. By Treatment Type
18.11.2.3. By Sales Channel
18.11.2.4. By Gender
18.12. China Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.12.2.1. By Disease Type
18.12.2.2. By Treatment Type
18.12.2.3. By Sales Channel
18.12.2.4. By Gender
18.13. Japan Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.13.2.1. By Disease Type
18.13.2.2. By Treatment Type
18.13.2.3. By Sales Channel
18.13.2.4. By Gender
18.14. South Korea Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.14.2.1. By Disease Type
18.14.2.2. By Treatment Type
18.14.2.3. By Sales Channel
18.14.2.4. By Gender
18.15. UAE Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.15.2.1. By Disease Type
18.15.2.2. By Treatment Type
18.15.2.3. By Sales Channel
18.15.2.4. By Gender
18.16. South Africa Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.16.2.1. By Disease Type
18.16.2.2. By Treatment Type
18.16.2.3. By Sales Channel
18.16.2.4. By Gender
18.17. Saudi Arabia Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032
18.17.2.1. By Disease Type
18.17.2.2. By Treatment Type
18.17.2.3. By Sales Channel
18.17.2.4. By Gender
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. iRestore Hair Growth System
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. iGrow Laser
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Theradome
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Curallux
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. LLC
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. LUTRONIC
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 2: Global Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 3: Global Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 4: Global Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 5: Global Market Value (US$Billion), By Gender, 2017 to 2021
Table 6: Global Market Value (US$Billion), By Gender, 2022 to 2032
Table 7: Global Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 8: Global Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 9: Global Market, By Region, 2017 to 2021
Table 10: Global Market, By Region, 2022 to 2032
Table 11: North America Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 12: North America Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 13: North America Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 14: North America Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 15: North America Market Value (US$Billion), By Gender, 2017 to 2021
Table 16: North America Market Value (US$Billion), By Gender, 2022 to 2032
Table 17: North America Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 18: North America Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 19: North America Market, By Country, 2017 to 2021
Table 20: North America Market, By Country, 2022 to 2032
Table 21: Latin America Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 22: Latin America Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 23: Latin America Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 24: Latin America Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 25: Latin America Market Value (US$Billion), By Gender, 2017 to 2021
Table 26: Latin America Market Value (US$Billion), By Gender, 2022 to 2032
Table 27: Latin America Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 28: Latin America Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 29: Latin America Market, By Country, 2017 to 2021
Table 30: Latin America Market, By Country, 2022 to 2032
Table 31: Europe Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 32: Europe Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 33: Europe Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 34: Europe Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 35: Europe Market Value (US$Billion), By Gender, 2017 to 2021
Table 36: Europe Market Value (US$Billion), By Gender, 2022 to 2032
Table 37: Europe Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 38: Europe Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 39: Europe Market, By Country, 2017 to 2021
Table 40: Europe Market, By Country, 2022 to 2032
Table 41: Asia Pacific Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 42: Asia Pacific Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 43: Asia Pacific Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 44: Asia Pacific Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 45: Asia Pacific Market Value (US$Billion), By Gender, 2017 to 2021
Table 46: Asia Pacific Market Value (US$Billion), By Gender, 2022 to 2032
Table 47: Asia Pacific Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 48: Asia Pacific Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 49: Asia Pacific Market, By Country, 2017 to 2021
Table 50: Asia Pacific Market, By Country, 2022 to 2032
Table 51: MEA Market Value (US$Billion), By Disease Type, 2017 to 2021
Table 52: MEA Market Value (US$Billion), By Disease Type, 2022 to 2032
Table 53: MEA Market Value (US$Billion), By Treatment Type, 2017 to 2021
Table 54: MEA Market Value (US$Billion), By Treatment Type, 2022 to 2032
Table 55: MEA Market Value (US$Billion), By Gender, 2017 to 2021
Table 56: MEA Market Value (US$Billion), By Gender, 2022 to 2032
Table 57: MEA Market Value (US$Billion), By Sales Channel, 2017 to 2021
Table 58: MEA Market Value (US$Billion), By Sales Channel, 2022 to 2032
Table 59: MEA Market, By Country, 2017 to 2021
Table 60: MEA Market, By Country, 2022 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$Billion
Figure 3: Global Market Share, By Disease Type, 2022 to 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 6: Global Market Share, By Treatment Type, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 8: Global Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 9: Global Market Share, By Sales Channel, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 12: Global Market Share, By Gender, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 14: Global Market Attractiveness Index, By Gender - 2022 to 2032
Figure 15: Global Market Share, By Region, 2022 to 2032
Figure 16: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032
Figure 17: Global Market Attractiveness Index, By Region - 2022 to 2032
Figure 18: North America Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 19: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$Billion
Figure 20: North America Market Share, By Disease Type, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 23: North America Market Share, By Treatment Type, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 25: North America Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 26: North America Market Share, By Sales Channel, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 28: North America Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 29: North America Market Share, By Gender, 2022 to 2032
Figure 30: North America Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 31: North America Market Attractiveness Index, By Gender - 2022 to 2032
Figure 32: North America Market Share, By Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 34: North America Market Attractiveness Index, By Country - 2022 to 2032
Figure 35: Latin America Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 36: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$Billion
Figure 37: Latin America Market Share, By Disease Type, 2022 to 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 39: Latin America Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 40: Latin America Market Share, By Treatment Type, 2022 to 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 42: Latin America Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 43: Latin America Market Share, By Sales Channel, 2022 to 2032
Figure 44: Latin America Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 45: Latin America Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 46: Latin America Market Share, By Gender, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 48: Latin America Market Attractiveness Index, By Gender - 2022 to 2032
Figure 49: Latin America Market Share, By Country, 2022 to 2032
Figure 50: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 51: Latin America Market Attractiveness Index, By Country - 2022 to 2032
Figure 52: Europe Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 53: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$Billion
Figure 54: Europe Market Share, By Disease Type, 2022 to 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 56: Europe Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 57: Europe Market Share, By Treatment Type, 2022 to 2032
Figure 58: Europe Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 59: Europe Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 60: Europe Market Share, By Sales Channel, 2022 to 2032
Figure 61: Europe Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 62: Europe Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 63: Europe Market Share, By Gender, 2022 to 2032
Figure 64: Europe Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 65: Europe Market Attractiveness Index, By Gender - 2022 to 2032
Figure 66: Europe Market Share, By Country, 2022 to 2032
Figure 67: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 68: Europe Market Attractiveness Index, By Country - 2022 to 2032
Figure 69: MEA Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 70: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$Billion
Figure 71: MEA Market Share, By Disease Type, 2022 to 2032
Figure 72: MEA Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 73: MEA Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 74: MEA Market Share, By Treatment Type, 2022 to 2032
Figure 75: MEA Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 76: MEA Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 77: MEA Market Share, By Sales Channel, 2022 to 2032
Figure 78: MEA Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 79: MEA Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 80: MEA Market Share, By Gender, 2022 to 2032
Figure 81: MEA Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 82: MEA Market Attractiveness Index, By Gender - 2022 to 2032
Figure 83: MEA Market Share, By Country, 2022 to 2032
Figure 84: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 85: MEA Market Attractiveness Index, By Country - 2022 to 2032
Figure 86: Asia Pacific Market Value (US$Billion) and Year-on-Year Growth, 2017 to 2032
Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$Billion
Figure 88: Asia Pacific Market Share, By Disease Type, 2022 to 2032
Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032
Figure 90: Asia Pacific Market Attractiveness Index, By Disease Type - 2022 to 2032
Figure 91: Asia Pacific Market Share, By Treatment Type, 2022 to 2032
Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 2032
Figure 93: Asia Pacific Market Attractiveness Index, By Treatment Type - 2022 to 2032
Figure 94: Asia Pacific Market Share, By Sales Channel, 2022 to 2032
Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By Sales Channel - 2022 to 2032
Figure 96: Asia Pacific Market Attractiveness Index, By Sales Channel - 2022 to 2032
Figure 97: Asia Pacific Market Share, By Gender, 2022 to 2032
Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Gender - 2022 to 2032
Figure 99: Asia Pacific Market Attractiveness Index, By Gender - 2022 to 2032
Figure 100: Asia Pacific Market Share, By Country, 2022 to 2032
Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 102: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032
